Rapid covid-19 mutation discrimination test for global sars-COV-2 variant surveillance
Ended Formula Grant Awarded Last action
- Award ID
- R43GH002389
- Recipient
-
JAN Biotech, Inc. UEI DKDUTDKCJQE6
- Awarding agency
-
Office of Financial Resources
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $275,766
Award facts
- Assistance listing
- 93.326 Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention
- Completion date
- Funding agency
- Office of the Director Centers for Disease Control and Prevention, Department of Health and Human Services
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $275,766 |
Quick answers
Who received award R43GH002389?
R43GH002389 was awarded to JAN Biotech, Inc. by Office of Financial Resources (Centers for Disease Control and Prevention) on August 9, 2022.
How much is award R43GH002389 worth?
$275,766 has been obligated on R43GH002389.
Which agency awarded R43GH002389?
Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43GH002389, with funding from Office of the Director (Centers for Disease Control and Prevention).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award